Lesaffre Enhances Its RD&I with Altar Acquisition
MARCQ-EN-BARŒUL, France - Lesaffre, a leading global player in fermentation and microorganisms, has recently announced the acquisition of Altar, a French start-up renowned for its expertise in Adaptive Laboratory Evolution (ALE). This acquisition will significantly augment Lesaffre's ability to innovate within the realms of fermentation and microbial technology, a move that promises to deliver impactful solutions.
Understanding Altar's Innovative Technology
Founded in 2017, Altar specializes in Adaptive Laboratory Evolution, a groundbreaking approach that allows the continuous cultivation of microorganisms in controlled settings. This technique ensures that strains can be selected for specific characteristics over extended periods. Altar's technology, along with the platform and associated know-how, opens doors for collaborative projects and advanced research services, laying the groundwork for substantial innovations here at Lesaffre.
CEO's Vision for Fermentation's Role
Brice-Audren Riché, the CEO of Lesaffre, highlights the company's commitment to the potential of fermentation. He states, "At Lesaffre, we harness the extraordinary capabilities of microorganisms to devise transformative solutions aimed at feeding a rapidly growing global population sustainably and safely. Our firm belief in innovation has made R&D a cornerstone of our strategy, enabling us to lead in bioprocesses and bioengineering. With this acquisition, we are poised to amplify our R&D efforts, bolstered by the establishment of the Lesaffre Campus, our advanced innovation hub. We have also previously acquired three companies specializing in fermentation research, maximizing our capabilities."
Significance of the Acquisition
The integration of Altar's expertise and technology into the Lesaffre ecosystem is expected to highlight the synergies already present in the company’s operations. This merger will not only enable a fluid transfer of knowledge and technical know-how but will also enhance the technological precision that Lesaffre has developed over the years. The acquisition was finalized recently, setting a strong foundation for future advancements.
Complementing Existing Technologies
This merger is a strategic move to bolster the current offerings of the Lesaffre Institute of Science and Technology (LIST). By integrating Altar's innovative technology, Lesaffre is poised to offer more complex strains, thereby enhancing the quality of its product portfolio. Christine M'Rini, Chief RD&I Officer, emphasizes the importance of this transition, saying, "Investing in our capabilities today ensures the development of healthier, sustainable products for tomorrow. We are excited to welcome Altar's talented team and collaborate on building innovative solutions together."
The Future of Biotechnology with Altar's Team
Located in Genopole, the premier French biocluster for biotechnology, Altar's 14 employees will join the Lesaffre Institute of Science and Technology. Their specialized knowledge will serve as a catalyst for Lesaffre's goals, further pushing the boundaries of innovation in fermentation technology.
Looking Ahead for Lesaffre and Altar
This acquisition not only simplifies Ginkgo Bioworks’ focus but also amplifies Lesaffre’s journey towards addressing major global challenges through enhanced biotechnological innovations. The synergy between Lesaffre and Altar’s team represents a key step forward, promising to unlock even more powerful solutions in the realm of microorganisms.
About Lesaffre
Lesaffre has been a pivotal player in fermentation for over a hundred years, boasting a turnover of 3 billion euros and a diverse workforce of 11,000 employees across 96 nationalities. This rich history fuels a collaborative spirit, as Lesaffre engages with customers, partners, and researchers to uncover innovative resources that address global needs in food, health, and sustainability. The urgency of nourishing a projected 9 billion individuals healthily by 2050 shapes their mission, with fermentation seen as a leading solution to this pressing challenge.
Conclusion
Lesaffre aims to lead in practical solutions that provide better nourishment and protect our planet. The acquisition of Altar marks another milestone in advancing their research and development strategy for a sustainable future.
Frequently Asked Questions
What is the significance of the acquisition of Altar by Lesaffre?
The acquisition of Altar enhances Lesaffre's innovative capabilities in fermentation and microbial technology, promoting significant advancements in research and development.
How does Altar's technology contribute to fermentation?
Altar specializes in Adaptive Laboratory Evolution, enabling the selection of microorganisms with specific properties, thus improving fermentation processes.
What is the vision of Lesaffre's CEO regarding fermentation?
CEO Brice-Audren Riché advocates for fermentation as a vital solution to address global food needs sustainably, underscoring the company's commitment to innovation.
Where will Altar's team be integrated within Lesaffre?
Altar's 14 employees will join the Lesaffre Institute of Science and Technology, contributing their expertise to bolster innovation efforts.
What are the long-term objectives of Lesaffre post-acquisition?
Lesaffre aims to enhance product quality, develop healthier solutions, and effectively meet the evolving needs of their customers through continued investments in research and technology.
